Western drugs derived from Chinese herbs
A research institute in Shanghai is developing drugs based on traditional Chinese medicine:
“Next month, the Shanghai Innovative Research Center of Traditional Chinese Medicine, a research and development institution for the modernization of traditional medicine, will apply to conduct clinical trials in Finland for its new antidepressant medicine extracted from herbs.
If the drug is approved, the center will be among a handful of companies that are launching therapeutic drugs derived from TCM onto the global market. “After seven years of study, we have extracted a single active ingredient from ginseng herbs. The pre-clinical trial has showed that this drug is safe and effective,” says Jiang Hongquan, an official with the center.
“The efficacy of this drug is very close to Eli Lilly’s Prozac, or fluoxetine, but the cost is much lower,” notes Jiang, adding that the active ingredient, extracted from ginseng herbs, is a brand-new ingredient that had not been previously identified. The development is a breakthrough for herbal medicine innovation and modernization, according to Jiang, who says that the center is also considering applying to the U.S. Food and Drug Administration (FDA) for clinical trial approval. Meanwhile, given the renewed global interest in TCM-derived drugs, the new medicine remains a closely guarded business secret.
The Shanghai Innovative Research Center is not alone in its effort to introduce Chinese herbal medicines into the mainstream market. Other companies have been doing the same thing for years, including Hutchison MediPharma (the R&D subsidiary of London AIM-listed Hutchison China MediTech), and Tasly Pharmaceutical Co., one of China’s largest TCM manufacturers.”
